ArticleJCO oncology practice2022

Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study.

Mengyang Di et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.